Piramal Pharma Limited (BOM:543635)

Market Cap	257.04B
Revenue (ttm)	91.51B
Net Income (ttm)	911.30M
Shares Out	n/a
EPS (ttm)	0.68
PE Ratio	282.05
Forward PE	135.63
Dividend	0.11 (0.06%)
Ex-Dividend Date	Jul 12, 2024

Volume	111,918
Average Volume	221,257
Open	203.95
Previous Close	200.95
Day's Range	200.80 - 204.40
52-Week Range	145.55 - 307.85
Beta	n/a
RSI	35.86
Earnings Date	Jul 28, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 6,719
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.